ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,161, issued on Sept. 30, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Methods for treating and pharmaceutical compositions" was invented by Eric Williams Mayoux (Gambais, France), Delphine Behr-Roussel (Viroflay, France) and Francois Giuliano (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods for improving glycemic control and for treating erectile dysfunction in a patient diagnosed with prediabetes, type 1 diabetes mellitus, type 2 diabetes mellitus or metabolic syndrome wherein a sodium glucose co-transporter 2 (SGLT2) inhibitor is administered to the patient. Furtherm...